Q2 2019 BioArctic AB Earnings Call Transcript
Hello and welcome to the BioArctic Q2 2019 report.(Operator Instructions) Just to remind you, this conference call is being recorded. Today, I am pleased to present CEO, Gunilla Osswald and CFO, Jan Mattsson. Please go ahead with your meeting.
()-
Thank you so much. And most welcome to the BioArctic interim report for the first half of 2019. I'm Gunilla Osswald, and I'm the CEO of BioArctic. And I will share the presentation here today with our CFO, Jan Mattsson.
Next slide, please. BioArctic is listed on Nasdaq Stockholm mid-cap stock market, and this is our disclaimer.
Next slide, please. So today, I will start with a summary of our significant projects -- progress that we have had in all our areas during the first half of this year. Last year was a fantastic year for BioArctic, and this first half of this year has continued to show great progress in all 3 disease areas as well as in our technology platform area.
If we start with Alzheimer's disease. Our most
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
